Calamos Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 335,374 shares of the healthcare conglomerate’s stock after purchasing an additional 26,481 shares during the period. UnitedHealth Group comprises approximately 0.7% of Calamos Advisors LLC’s portfolio, making the stock its 17th biggest position. Calamos Advisors LLC’s holdings in UnitedHealth Group were worth $169,652,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of UNH. State Street Corp increased its position in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after buying an additional 563,554 shares during the period. Geode Capital Management LLC boosted its holdings in UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after purchasing an additional 318,039 shares during the period. Franklin Resources Inc. increased its holdings in shares of UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares during the period. International Assets Investment Management LLC boosted its stake in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the period. Finally, Fisher Asset Management LLC raised its holdings in shares of UnitedHealth Group by 3.5% in the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock valued at $1,869,320,000 after acquiring an additional 107,097 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on the stock. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Morgan Stanley dropped their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. TD Cowen lifted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Stephens increased their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Stock Performance
Shares of UNH opened at $548.65 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company’s fifty day moving average is $536.17 and its two-hundred day moving average is $565.20. The stock has a market capitalization of $504.91 billion, a P/E ratio of 35.40, a P/E/G ratio of 1.48 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the business posted $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.53%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- How to Profit From Growth Investing
- Boeing: Charting a Course for Recovery and Redemption
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Top 3 High-Momentum Companies Analysts Are Still Bullish On
- Low PE Growth Stocks: Unlocking Investment Opportunities
- How to Invest in Small Cap Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.